PERERA, K. S., DD. BOASQUEVISQUE, P. RAO MELACINI, A. TAYLOR, A. CHENG, G. J. HANKEY, S. LEE, J. M. FABREGAS, S. F. AMERISO, T. S. FIELD, A. ARAUZ, S. B. COUTTS, M. ARNOLD, Robert MIKULÍK, D. TONI, J. MANDZIA, R. C. VELTKAMP, E. MESEGUER, K. G. HAEUSLER and R. G. HART. Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source The Young ESUS Longitudinal Cohort Study. JAMA neurology. Chicago, IL: American Medical Association, 2022, vol. 79, No 5, p. 450-458. ISSN 2168-6149. Available from: https://dx.doi.org/10.1001/jamaneurol.2022.0048.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Evaluating Rates of Recurrent Ischemic Stroke Among Young Adults With Embolic Stroke of Undetermined Source The Young ESUS Longitudinal Cohort Study
Authors PERERA, K. S. (guarantor), DD. BOASQUEVISQUE, P. RAO MELACINI, A. TAYLOR, A. CHENG, G. J. HANKEY, S. LEE, J. M. FABREGAS, S. F. AMERISO, T. S. FIELD, A. ARAUZ, S. B. COUTTS, M. ARNOLD, Robert MIKULÍK (203 Czech Republic, belonging to the institution), D. TONI, J. MANDZIA, R. C. VELTKAMP, E. MESEGUER, K. G. HAEUSLER and R. G. HART.
Edition JAMA neurology, Chicago, IL, American Medical Association, 2022, 2168-6149.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30210 Clinical neurology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 29.000
RIV identification code RIV/00216224:14110/22:00126256
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1001/jamaneurol.2022.0048
UT WoS 000770397500002
Keywords in English Ischemic Stroke; Embolic Stroke; Young Adults
Tags 14110127, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 14/7/2022 10:47.
Abstract
IMPORTANCE Cryptogenic strokes constitute approximately 40% of ischemic strokes in young adults, and most meet criteria for the embolic stroke of undetermined source (ESUS). Two randomized clinical trials, NAVIGATE ESUS and RESPECT ESUS, showed a high rate of stroke recurrence in older adults with ESUS but the prognosis and prognostic factors among younger individuals with ESUS is uncertain. OBJECTIVE To determine rates of and factors associated with recurrent ischemic stroke and death and new-onset atrial fibrillation (AF) among young adults. DESIGN, SETTING, AND PARTICIPANTS This multicenter longitudinal cohort study with enrollment from October 2017 to October 2019 and a mean follow-up period of 12 months ending in October 2020 included 41 stroke research centers in 13 countries. Consecutive patients 50 years and younger with a diagnosis of ESUS were included. Of 576 screened, 535 participants were enrolled after 1 withdrew consent, 41 were found to be ineligible, and 2 were excluded for other reasons. The final follow-up visit was completed by 520 patients. MAIN OUTCOMES AND MEASURES Recurrent ischemic stroke and/or death, recurrent ischemic stroke, and prevalence of patent foramen ovale (PFO). RESULTS The mean (SD) age of participants was 40.4 (7.3) years, and 297 (56%) participants were male. The most frequent vascular risk factors were tobacco use (240 patients [45%]), hypertension (118 patients [22%]), and dyslipidemia (109 patients [20%]). PFO was detected in 177 participants (50%) who had transthoracic echocardiograms with bubble studies. Following initial ESUS, 468 participants (88%) were receiving antiplatelet therapy, and 52 (10%) received anticoagulation. The recurrent ischemic stroke and death rate was 2.19 per 100 patient-years, and the ischemic stroke recurrence rate was 1.9 per 100 patient-years. Of the recurrent strokes, 9 (64%) were ESUS, 2 (14%) were cardioembolic, and 3 (21%) were of other determined cause. AF was detected in 15 participants (2.8%; 95% CI, 1.6-4.6). In multivariate analysis, the following were associated with recurrent ischemic stroke: history of stroke or transient ischemic attack (hazard ratio, 5.3; 95% CI, 1.8-15), presence of diabetes (hazard ratio, 4.4; 95% CI, 1.5-13), and history of coronary artery disease (hazard ratio, 10; 95% CI, 4.8-22). CONCLUSIONS AND RELEVANCE In this large cohort of young adult patients with ESUS, there was a relatively low rate of subsequent ischemic stroke and a low frequency of new-onset AF. Most recurrent strokes also met the criteria for ESUS, suggesting the need for future studies to improve our understanding of the underlying stroke mechanism in this population.
PrintDisplayed: 25/4/2024 02:06